General
Preferred name
PIPENZOLATE
Synonyms
PIPENZOLATE BROMIDE ()
Piptal ()
Pipenzolate Methylbromide ()
NSC-4347 ()
JB-323 ()
Pipenzolone Bromide ()
Pipenzolate cation ()
Pipenzolate ion ()
P&D ID
PD013303
CAS
125-51-9
13473-38-6
Tags
available
drug
Drug Status
experimental
approved
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Pipenzolate, a muscarinic receptor antagonist, commonly existed as bromide salt form and could be used as a spasmolytic and could probably effective in aid therapy of Alzheimer's disease.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Pipenzolate bromide, a muscarinic receptor antagonist, was once considered as a spasmolytic.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Molecular Weight
354.21
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
2
cLogP
3.09
TPSA
46.53
Fraction CSP3
0.41
Chiral centers
2.0
Largest ring
6.0
QED
0.66
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Solubility
10 mM in H2O
Source data
